Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2016/V13/I7/437

[1] Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury[J]. World J Gastroentreol, 2008, 14(44):6774-6785.
[2] Stahlmann R, Lode H. Safety considerations of fluoroquinolones in elderly[J]. Drugs Aging, 2010, 27(3):193-209.
[3] Schwalm J D, Lee C H. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patients CNAJ[J]. 2003, 168 (7): 847-848．
[4] Titos-Arcos J C, Hallal H, Robles M, et al. Acute cholestatic hepatitis associated with levofloxacin[J]. Gastroenterol Hepatol, 2011, 34(5):369-370.
[5] Figueira-Coelho J, Pereira O, Picado B, et al. Acute hepatitis associated with the use of levofloxacin[J]. Clin Ther. 2010, 32(10):1733-1737.
[6] Verma R, Dhamija R, Batts D H, et al. Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man a case report[J]. Cases J, 2009, 2:8063.
[7] 罗晓, 程晟. 左氧氟沙星注射液致过敏性休克及肝功能损伤[J]. 中国药物应用于监测, 2010,7(5):323-324.
[8] 刘春梅, 李海红, 王伟. 左氧氟沙星静脉输注致关节肿痛伴肝功能异常[J]. 药物不良反应杂志, 2008,10(3):208.
[9] 谢丽.盐酸左氧氟沙星致药物性肝病一例药学监护分析[J].临床合理用药,2011,4(3):64-66.
[10] 严定强, 彭婕. 左氧氟沙星致肝损害合并白细胞减少1例[J]. 药学与临床研究, 2011,19(3):274.
[11] 海啸, 李军祥, 江义墩，等. 左氧氟沙星致严重肝损害[J]. 药物不良反应杂志, 2009,11(1):49-53.
[12] 李淑萍. 左氧氟沙星致暴发性肝功能衰竭1例[J]. 中国热带医学, 2005,5(1):94,73.
[13] 张志芬, 张鹏. 左氧氟沙星致肝肾功能异常及精神症状[J]. 药物不良反应杂志, 2006,8(3):223-224.
[14] 孙明莉, 巨名飞, 韩秀丽，等. 左氧氟沙星致急性药物性肝炎l例[J].临床肝胆志, 2007,23(3):240-241.
[15] 蔡少平, 范振平, 张文，等. 左氧氟沙星致听力下降和肝损害1 例[J]. 实用肝脏病杂志, 2011,14(4):305-306.
[16] 郑盼盼，洪远. 对1例老年患者使用多种药物致肝功能损害的用药分析[J].药品评价, 2013,20(10): 44-47.
[17] 杨蕊, 黄欣, 韩毅，等.静脉滴注莫西沙星致肝功能异常[J]. 药物不良反应杂志, 2013,15(12):105-107.
[18] 吕栋, 赵敏. 静脉滴注莫西沙星致急性肝损伤[J]. 药物不良反应杂志, 2012,14(6):391-393.
[19] 郑显维, 洪冰. 莫西沙星致中枢神经毒性、肝功能异常、白细胞减少９例不良反应报告分析[J]. 海峡药学, 2013,25(12): 210-212.
[20] 马丽娜, 崔云婧, 冯明. 静脉滴注莫西沙星致肝功能异常5例[J]. 中国药师, 2009,12(6):798-801.
[21] 王兰霞, 强生萍. 莫西沙星致肝功能异常1例[J]. 中国药物警戒, 2012,9(7):445-446.
[22] 袁祥萍, 程振田, 潘玉兴，等. 莫西沙星致肝肾功能异常[J]. 药物不良反应杂志, 2010,12(2):133-136.
[23] 徐焕春, 乔逸, 王婧雯. 注射用头孢哌酮钠/舒巴坦钠和盐酸莫西沙星片致严重肝损害[J]. 中国药物应用与监测, 2013,10(2):122-124.
[24] 李秀荣, 张燕娥, 陈金萍. 盐酸莫西沙星氯化钠注射液致肝损伤1 例[J]. 中国药师, 2013,16(12):1894-1895.
[25] 蒋少红, 方洁. 抗菌药物致肝损伤并文献复习[J]. 中国医药, 2011,6(3):331-333.
[26]卜艳丽, 代晓燕, 李成. 莫西沙星所致肝功能异常文献概述[J]. 中国药物滥用防治杂志, 2013,19(6):360.
[27] Ho C C, Chen Y C, Hu F C, et al. Safety of Fluoroquinolone Use in
Patients with Hepatotoxicity Induced by Anti-Tuberculosis Regimens[J].Clin Infect Dis, 2009, 48(11):1526-33.
[28] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志, 2015,23(11):810-820.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.